anxiety
ANXIETY

Anxiety disorders are disorders wherein the patient experiences uncontrollable fear or anxiety with behavioral disturbances that affects normal functioning.

Generalized anxiety disorder is having excessive anxiety and worry occurring for at least 6 months about several events or activities. The person finds it difficult to control the worry.
Panic disorder is when the person experienced recurrent unexpected panic attacks.
Social anxiety disorder is marked and persistent fear of social or performance situations in which the person is exposed to unfamiliar people or to possible scrutiny by others.

Anxiety References

  1. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005 Nov;19(6):567-596. PMID: 16272179
  2. Bruce TJ, Saeed SA. Social anxiety disorder: a common under-recognized mental disorder. Am Fam Physician. 1999 Nov;60(8):2311-2322. PMID: 10593322
  3. Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. 2006 Jul;51(8)(Suppl 2):9S-91S. PMID: 16933543
  4. Culpepper L. Use of algorithms to treat anxiety in primary care. J Clin Psychiatry. 2003;64(Suppl 2):30-33. PMID: 12625797
  5. Gliatto MF. Generalized anxiety disorder. Am Fam Physician. 2000 Oct;62(7):1591-1600. PMID: 11037076
  6. Gorman JM. Treating generalized anxiety disorder. J Clin Psychiatry. 2003;64(Suppl 2):24-29. PMID: 12625796
  7. Hicks D, Cummings T Jr, Epstein SA. An approach to the patient with anxiety. Med Clin North Am. 2010 Nov;94(6):1127-1139. PMID: 20951274
  8. Kavan MG, Elsasser G, Barone EJ. Generalized anxiety disorder: practical assessment and management. Am Fam Physician. 2009 May;79(9):785-791. PMID: 20141098
  9. Lepine JP. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry. 2002;63(Suppl 14):004-8. PMID: 12562112
  10. Hidalgo RB, Davidson JR. Generalized anxiety disorder. An important clinical concern. Med Clin North Am. 2001 May;85(3):691-710. PMID: 11349480
  11. Radomsky AS, Otto MW. Cognitive-behavioral therapy for social anxiety disorder. Psychiatr Clin North Am. 2001 Dec;24(4):805-815. PMID: 11723634
  12. Rickels K, Rynn M. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry. 2002;63(Suppl 14):009-16. PMID: 12562113
  13. Raj BA, Sheehan DV. Social anxiety disorder. Med Clin North Am. 2001 May;85(3):711-733. PMID: 11349481
  14. Rickels K, Moller HJ. Anxiety: new treatment perspectives [introduction]. J Clin Psychiatry. 2002;63(Suppl 14):3
  15. Schneider FR. Clinical practice: social anxiety disorder. N Engl J Med. 2006 Sep;335(10):1029-1036. PMID: 16957148
  16. Sheehan DV. The management of panic disorder. J Clin Psychiatry. 2002;63(Suppl 14):17-21. PMID: 12562114
  17. Van Ameringen M. Pharmacotherapy of social anxiety disorder at the turn of the millennium. Psychiatr Clin North Am. 2001 Dec;24(4):783-803. PMID: 11723633
  18. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  19. MedWorm http://www.medworm.com/rss/index.php/Psychiatry/172/ www.medworm.com/rss/medicalfeeds/specialities/Psychiatry-News.xml
  20. Stein MB, Goin MK, Pollack MH, et al, for the Work Group on Panic Disorder. American Psychiatric Association (APA). Practice guideline for the treatment of patients with panic disorder. 2nd ed. 2009
  21. Ministry of Health Singapore and National Medical Research Council. Clinical practice guideline: anxiety disorders. MOH (Singapore). http://www.moh.gov.sg. Nov 2003.
  22. Questionnaires. Identifying Depression as a Comorbid Condition. http://idacc.healthbase.info/. Accessed 05 Aug 2013.
  23. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care. CG 113. NICE. http://www.nice.org.uk. Jan 2011.
  24. Institute for Clinical Systems Improvement (ICSI). Health care guideline: major depression, panic disorder and generalized anxiety disorder in adults in primary care: collaborative decision-making management. ICSI. http://www.icsi.org. May 2002.
  25. The Guideline Development Group, National Collaborating Centre and NICE project team. Social anxiety disorder: recognition, assessment and treatment. NICE. http://www.nice.org.uk. May 2013. Accessed 01 Aug 2013.
  26. McIntosh A, Cohen A, Turnbull N, et al. Clinical guidelines for the management of anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. NICE. http://www.nice.org.uk. Dec 2004.
  27. American Psychiatric Association. Anxiety disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:190-222.
  28. Bandelow B, Sher L, Benevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. PMID: 22540422
  29. Ministry of Health Singapore. Clinical practice guidelines anxiety disorders. MOH Singapore. http://www.moh.gov.sg/cpg. Jan 2015. Accessed 22 Sep 2015.
  30. Stahl SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical application. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 2013:111.
  31. Bystritsky A. Pharmacotherapy for generalized anxiety disorder in adults. UpToDate. https://www.uptodate.com. Apr 2016 .
  32. Kreys TJ, Phan SV. A literature review of quetiapine for generalized anxiety disorder. Pharmacotherapy. 2015 Feb;35(2):175-188. doi: 10.1002/phar.1529. Accessed 10 Aug 2016. PMID: 25689246
  33. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014 May;28(5):403-439. doi: 10.1177/0269881114525674. PMID: 24713617
  34. Craske M. Psychotherapy for generalized anxiety disorder in adults. UpToDate. https://www.uptodate.com. 1 Mar 2018.
  35. Craske M, Bystritsky A. Approach to treating generalized anxiety disorder in adults. UpToDate. https://www.uptodate.com. 27 Aug 2020. Accessed 21 Oct 2020.
  36. Hofmann SG. Psychotherapy for social anxiety disorder in adults. UpToDate. https://www.uptodate.com. 14 Aug 2019.
  37. Katzman MA, Bleau P, Blier P. Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1:S1). doi: 10.1186/1471-244X-14-S1-S1. Accessed 23 Oct 2020. PMID: 25081580
  38. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. NICE. https://www.nice.org.uk. 26 Jan 2011.
  39. Reddy YCJ, Sudhir PM, Manjula M, et al. Clinical practice guidelines for cognitive-behavioral therapies in anxiety disorders and obsessive-compulsive and related disorders. Indian J Psychiatry. 2020 Jan;62(Suppl 2):S230-S250. doi: 10.4103/psychiatry.IndianJPsychiatry_773_19. Accessed 15 Oct 2020. PMID: 32055066
  40. Roy-Byrne PP, Craske M. Approach to treating panic disorder with or without agoraphobia in adults. UpToDate. https://www.uptodate.com. 11 Apr 2019. Accessed 21 Oct 2020.
  41. Roy-Byrne PP. Pharmacotherapy for panic disorder with or without agoraphobia in adults. UpToDate. https://www.uptodate.com. 21 Oct 2020.
  42. Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther. 2019 Dec;2014:107402. doi: 0.1016/j.pharmthera.2019.107402. Accessed 28 Oct 2020. PMID: 31470029
  43. Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019 Feb;393(10173):768-777. doi: 10.1016/S0140-6736(18)31793-8. PMID: 30712879
  44. Stein MB, Taylor CT. Approach to treating social anxiety disorder in adults. UpToDate. https://www.uptodate.com. 5 Jun 2019.
  45. Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). Jun 2016. Accessed 23 Oct 2020.
  46. Walter HJ, Bukstein OG, Abright AR, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1107-1124. doi: 10.1016/j.jaac.2020.05.005. Accessed 15 Oct 2020. PMID: 32439401
  47. Andrews G, Bell C, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust NZ J Psychiatry. 2018;52(12):1109-1172.
  48. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017 Jun;19(2):93-107. doi: 10.31887/DCNS.2017.19.2/bbandelow. PMID: 28867934
  49. Gautam D, Jain A, Gautam M, et al. Clinical practice guidelines for the management of generalised anxiety disorder (GAD) and panic disorder (PD). Indian J Psychiatry. 2017 Jan;59(Suppl 1):S67-S73. doi: 10.4103/0019-5545.196975. PMID: 28216786
  50. National Collaborating Centre for Mental Health. Social anxiety disorder: recognition, assessment and treatment. National clinical guideline number 159. NICE. http://www.nice.org.uk/. Mar 2020.
  51. Stein MB. Pharmacotherapy for social anxiety disorder in adults. UpToDate. https://www.uptodate.com. 16 Apr 2020.
  52. Baldwin D. Generalized anxiety disorder in adults: epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. https://www.uptodate.com. 3 Apr 2018. Accessed 21 Oct 2020.
  53. Aziz MO, Mehrinejad SA, Hashemian K, et al. Integrative therapy (short-term psychodynamic psychotherapy & cognitive-behavioral therapy) and cognitive-behavioral therapy in the treatment of generalized anxiety disorder: a randomized controlled trial. Complement Ther Clin Pract. 2020 May;39:101122. doi: 10.1016/j.ctcp.2020.101122. PMID: 32379661
  54. Burgess DJ, Beach MC, Saha S. Mindfulness practice: a promising approach to reducing the effects of clinician implicit bias on patients. Patient Educ Couns. 2017 Feb;100(2):372-376. doi: 10.1016/j.pec.2016.09.005. PMID: 27665499
  55. Hofmann SG, Gómez AF. Mindfulness-based interventions for anxiety and depression. Psychiatr Clin North Am. 2017 Dec;40(4):739-749. doi: 10.1016/j.psc.2017.08.008. PMID: 29080597
  56. Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015 May;91(9):617-624. PMID: 25955736
  57. Pettersson A, Modin S, Wahlström R, et al. The Mini-International Neuropsychiatric Interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care: a mixed-methods study. BMC Fam Pract. 2018 Jan;19(1):19. doi: 10.1186/s12875-017-0674-5. PMID: 29368585
  58. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33;quiz 34-57. Accessed 24 May 2021. PMID: 9881538
Editor's Recommendations
Most Read Articles
03 Jun 2021

Mental health of most adults in the UK remained resilient or returned to around the same level prior to the coronavirus disease 2019 (COVID-19) pandemic, although around one in nine had deteriorating or consistently poor mental health, results of a recent latent class trajectory analysis have shown. 

01 Jun 2021
Despite missing medical follow-ups due to the COVID-19 pandemic, breast cancer survivors with high psychological resilience and spiritual wellbeing (SWB) show lower fear of cancer recurrence (FCR), a new study has found.
Roshini Claire Anthony, 28 Apr 2021

The risk of depression following a stroke may be greater in women than men, according to a retrospective study from the US presented at ISC 2021.

Roshini Claire Anthony, 19 Apr 2021

Stroke survivors may be at an elevated risk of suicide attempts and deaths, according to results of a systematic review and meta-analysis.